|
⚲
|
| Keyboard |
| Li Yishu
✚
|
|
|---|---|
| CIK # | 0001669923 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001669923] | |
| 4 | [0001669923] | |
| SC 13D | [0001669923] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Li Yishu | Cesca Therapeutics Inc | [2016-03-25] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cesca Therapeutics Inc | |
| Boyalife Asset Holding II Inc | |
| Boyalife Hong Kong Ltd | |
| Xu Xiaochun | |
| Li Yishu | |
| Boyalife Group Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cesca Therapeutics Inc KOOL
Common Stock
|
2019-12-26 | Buy | 683,824 | $2,277,134.00 | 1,557,158,880,416 |
|
Cesca Therapeutics Inc KOOL
Common Stock
|
2019-12-26 | Buy | 683,824 | $2,277,134.00 | 1,557,158,880,416 |
|
Cesca Therapeutics Inc KOOL
Warrants to Purchase Common Stock · derivative
|
2019-12-26 | Buy | 352,942 | $10.00 | 3,529,420 |
|
Cesca Therapeutics Inc KOOL
Warrants to Purchase Common Stock · derivative
|
2019-12-26 | Buy | 352,942 | $10.00 | 3,529,420 |
|
Cesca Therapeutics Inc KOOL
Participation Interest in Convertible Note · derivative
|
2019-12-20 | Buy | $2,000,000.00 | ||
|
Cesca Therapeutics Inc KOOL
Second Amended and Restated Convertible Promissory Note · derivative
|
2018-04-16 | Grant | $1.61 |